GSK inks deal to buy lupus therapy from Chimagen for USD300 million
29 Outubro 2024 - 9:48AM
Alliance News
GSK PLC on Tuesday
said that it has signed a deal to buy CMG1A46 from Chimagen
Biosciences for USD300 million upfront ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Gsk (LSE:GSK)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Gsk (LSE:GSK)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
